Loading…

Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle

Schild regressions for the selective AT(1) and AT(2) receptor antagonists, losartan and PD123319 (S-[+]-1-[(4-dimethylamino]-3-methylphenyl)methyl]-5-[diphenylacetyl]-4,5,6,7-tetrahydro-1H-imidazol[4,5-c]pyridine-6-carboxilic acid), respectively, were calculated to analyze the heterogeneity of recep...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacology and experimental therapeutics 2002-10, Vol.303 (1), p.333-339
Main Authors: de Godoy, Márcio A F, de Oliveira, Ana M
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 339
container_issue 1
container_start_page 333
container_title The Journal of pharmacology and experimental therapeutics
container_volume 303
creator de Godoy, Márcio A F
de Oliveira, Ana M
description Schild regressions for the selective AT(1) and AT(2) receptor antagonists, losartan and PD123319 (S-[+]-1-[(4-dimethylamino]-3-methylphenyl)methyl]-5-[diphenylacetyl]-4,5,6,7-tetrahydro-1H-imidazol[4,5-c]pyridine-6-carboxilic acid), respectively, were calculated to analyze the heterogeneity of receptor populations in the rat anococcygeus muscle. For a one-receptor system, the Schild regression has a slope of unity and an intercept of K(B) for competitive antagonists. However, in a two-receptor system, a deviation from the single-receptor plot will occur. This is predicated on the assumption that the secondary receptor is less sensitive to the antagonist than the primary receptor. Results showed that the Schild regression for losartan did not produce a slope of unity, and PD123319 did not produce any effect. However, tissue incubation with losartan plus PD123319 resulted in a Schild regression that has a slope of unity and a pK(B) of 9.32. In the presence of prazosin, an alpha(1)-adrenoceptor antagonist, losartan did not produce any effect. Conversely, PD123319 enhanced the angiotensin II (Ang II)-induced contraction in a concentration-dependent fashion, suggesting an inhibitory AT(2)-mediated effect. This effect was confirmed with assays that showed a relaxant response induced by Ang II on precontracted tissues incubated with prazosin. PD123319 and N(G)-nitro-L-arginine methyl ester [nitric-oxide (NO) synthase inhibitor)] markedly inhibited the relaxant response of Ang II. In contrast, losartan did not produce any significant effect. Consequently, results show that the mechanism underlying the AT(2)-mediated effect is highly dependent on NO generation. Results indicate the presence of a heterogeneous angiotensin receptor population in the rat anococcygeus muscle following a negative cross-talk relationship between the AT(1) and AT(2) subtypes.
doi_str_mv 10.1124/jpet.102.036970
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72093930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72093930</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-5b499a0e8d5ac672f066d939391c45e376cb7c7bf39397eb3c5b4c295a7802f03</originalsourceid><addsrcrecordid>eNo1kL1PwzAQxT2AaCnMbMgTgiHFH7GdjFVUPqRKLGVhiRznWlKSOOQcof73JKLohnt393tvOEJuOFtyLuLHQwdhyZlYMqlTw87InDEhIqm0mpFLxANjPI61vCAzLoRUQidz8pH1HjEKtv6iBYQfgJautvf8gdq2nJSY1L7yAVqsWtqDgy74Huk02DAevfPOHfcwIMXG-_BJmwFdDVfkfGdrhOtTX5D3p_U2e4k2b8-v2WoTdVymIVJFnKaWQVIq67QRO6Z1mcqxuIsVSKNdYZwpdtPKQCHd6HAiVdYkbKTlgtz95Xa9_x4AQ95U6KCubQt-wNwINsVN4O0JHIoGyrzrq8b2x_z_G_IXOB1e_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72093930</pqid></control><display><type>article</type><title>Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle</title><source>Freely Accessible Journals</source><creator>de Godoy, Márcio A F ; de Oliveira, Ana M</creator><creatorcontrib>de Godoy, Márcio A F ; de Oliveira, Ana M</creatorcontrib><description>Schild regressions for the selective AT(1) and AT(2) receptor antagonists, losartan and PD123319 (S-[+]-1-[(4-dimethylamino]-3-methylphenyl)methyl]-5-[diphenylacetyl]-4,5,6,7-tetrahydro-1H-imidazol[4,5-c]pyridine-6-carboxilic acid), respectively, were calculated to analyze the heterogeneity of receptor populations in the rat anococcygeus muscle. For a one-receptor system, the Schild regression has a slope of unity and an intercept of K(B) for competitive antagonists. However, in a two-receptor system, a deviation from the single-receptor plot will occur. This is predicated on the assumption that the secondary receptor is less sensitive to the antagonist than the primary receptor. Results showed that the Schild regression for losartan did not produce a slope of unity, and PD123319 did not produce any effect. However, tissue incubation with losartan plus PD123319 resulted in a Schild regression that has a slope of unity and a pK(B) of 9.32. In the presence of prazosin, an alpha(1)-adrenoceptor antagonist, losartan did not produce any effect. Conversely, PD123319 enhanced the angiotensin II (Ang II)-induced contraction in a concentration-dependent fashion, suggesting an inhibitory AT(2)-mediated effect. This effect was confirmed with assays that showed a relaxant response induced by Ang II on precontracted tissues incubated with prazosin. PD123319 and N(G)-nitro-L-arginine methyl ester [nitric-oxide (NO) synthase inhibitor)] markedly inhibited the relaxant response of Ang II. In contrast, losartan did not produce any significant effect. Consequently, results show that the mechanism underlying the AT(2)-mediated effect is highly dependent on NO generation. Results indicate the presence of a heterogeneous angiotensin receptor population in the rat anococcygeus muscle following a negative cross-talk relationship between the AT(1) and AT(2) subtypes.</description><identifier>ISSN: 0022-3565</identifier><identifier>DOI: 10.1124/jpet.102.036970</identifier><identifier>PMID: 12235268</identifier><language>eng</language><publisher>United States</publisher><subject>Angiotensin II - pharmacology ; Animals ; Imidazoles - pharmacology ; Kinetics ; Losartan - pharmacology ; Male ; Muscle Contraction - drug effects ; Muscle, Smooth - drug effects ; Muscle, Smooth - physiology ; NG-Nitroarginine Methyl Ester - pharmacology ; Prazosin - pharmacology ; Pyridines - pharmacology ; Rats ; Rats, Wistar ; Receptor Cross-Talk - physiology ; Receptor, Angiotensin, Type 1 ; Receptor, Angiotensin, Type 2 ; Receptors, Angiotensin - physiology</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2002-10, Vol.303 (1), p.333-339</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12235268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Godoy, Márcio A F</creatorcontrib><creatorcontrib>de Oliveira, Ana M</creatorcontrib><title>Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Schild regressions for the selective AT(1) and AT(2) receptor antagonists, losartan and PD123319 (S-[+]-1-[(4-dimethylamino]-3-methylphenyl)methyl]-5-[diphenylacetyl]-4,5,6,7-tetrahydro-1H-imidazol[4,5-c]pyridine-6-carboxilic acid), respectively, were calculated to analyze the heterogeneity of receptor populations in the rat anococcygeus muscle. For a one-receptor system, the Schild regression has a slope of unity and an intercept of K(B) for competitive antagonists. However, in a two-receptor system, a deviation from the single-receptor plot will occur. This is predicated on the assumption that the secondary receptor is less sensitive to the antagonist than the primary receptor. Results showed that the Schild regression for losartan did not produce a slope of unity, and PD123319 did not produce any effect. However, tissue incubation with losartan plus PD123319 resulted in a Schild regression that has a slope of unity and a pK(B) of 9.32. In the presence of prazosin, an alpha(1)-adrenoceptor antagonist, losartan did not produce any effect. Conversely, PD123319 enhanced the angiotensin II (Ang II)-induced contraction in a concentration-dependent fashion, suggesting an inhibitory AT(2)-mediated effect. This effect was confirmed with assays that showed a relaxant response induced by Ang II on precontracted tissues incubated with prazosin. PD123319 and N(G)-nitro-L-arginine methyl ester [nitric-oxide (NO) synthase inhibitor)] markedly inhibited the relaxant response of Ang II. In contrast, losartan did not produce any significant effect. Consequently, results show that the mechanism underlying the AT(2)-mediated effect is highly dependent on NO generation. Results indicate the presence of a heterogeneous angiotensin receptor population in the rat anococcygeus muscle following a negative cross-talk relationship between the AT(1) and AT(2) subtypes.</description><subject>Angiotensin II - pharmacology</subject><subject>Animals</subject><subject>Imidazoles - pharmacology</subject><subject>Kinetics</subject><subject>Losartan - pharmacology</subject><subject>Male</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - physiology</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Prazosin - pharmacology</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor Cross-Talk - physiology</subject><subject>Receptor, Angiotensin, Type 1</subject><subject>Receptor, Angiotensin, Type 2</subject><subject>Receptors, Angiotensin - physiology</subject><issn>0022-3565</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNo1kL1PwzAQxT2AaCnMbMgTgiHFH7GdjFVUPqRKLGVhiRznWlKSOOQcof73JKLohnt393tvOEJuOFtyLuLHQwdhyZlYMqlTw87InDEhIqm0mpFLxANjPI61vCAzLoRUQidz8pH1HjEKtv6iBYQfgJautvf8gdq2nJSY1L7yAVqsWtqDgy74Huk02DAevfPOHfcwIMXG-_BJmwFdDVfkfGdrhOtTX5D3p_U2e4k2b8-v2WoTdVymIVJFnKaWQVIq67QRO6Z1mcqxuIsVSKNdYZwpdtPKQCHd6HAiVdYkbKTlgtz95Xa9_x4AQ95U6KCubQt-wNwINsVN4O0JHIoGyrzrq8b2x_z_G_IXOB1e_w</recordid><startdate>200210</startdate><enddate>200210</enddate><creator>de Godoy, Márcio A F</creator><creator>de Oliveira, Ana M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200210</creationdate><title>Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle</title><author>de Godoy, Márcio A F ; de Oliveira, Ana M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-5b499a0e8d5ac672f066d939391c45e376cb7c7bf39397eb3c5b4c295a7802f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Angiotensin II - pharmacology</topic><topic>Animals</topic><topic>Imidazoles - pharmacology</topic><topic>Kinetics</topic><topic>Losartan - pharmacology</topic><topic>Male</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - physiology</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Prazosin - pharmacology</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor Cross-Talk - physiology</topic><topic>Receptor, Angiotensin, Type 1</topic><topic>Receptor, Angiotensin, Type 2</topic><topic>Receptors, Angiotensin - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Godoy, Márcio A F</creatorcontrib><creatorcontrib>de Oliveira, Ana M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Godoy, Márcio A F</au><au>de Oliveira, Ana M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2002-10</date><risdate>2002</risdate><volume>303</volume><issue>1</issue><spage>333</spage><epage>339</epage><pages>333-339</pages><issn>0022-3565</issn><abstract>Schild regressions for the selective AT(1) and AT(2) receptor antagonists, losartan and PD123319 (S-[+]-1-[(4-dimethylamino]-3-methylphenyl)methyl]-5-[diphenylacetyl]-4,5,6,7-tetrahydro-1H-imidazol[4,5-c]pyridine-6-carboxilic acid), respectively, were calculated to analyze the heterogeneity of receptor populations in the rat anococcygeus muscle. For a one-receptor system, the Schild regression has a slope of unity and an intercept of K(B) for competitive antagonists. However, in a two-receptor system, a deviation from the single-receptor plot will occur. This is predicated on the assumption that the secondary receptor is less sensitive to the antagonist than the primary receptor. Results showed that the Schild regression for losartan did not produce a slope of unity, and PD123319 did not produce any effect. However, tissue incubation with losartan plus PD123319 resulted in a Schild regression that has a slope of unity and a pK(B) of 9.32. In the presence of prazosin, an alpha(1)-adrenoceptor antagonist, losartan did not produce any effect. Conversely, PD123319 enhanced the angiotensin II (Ang II)-induced contraction in a concentration-dependent fashion, suggesting an inhibitory AT(2)-mediated effect. This effect was confirmed with assays that showed a relaxant response induced by Ang II on precontracted tissues incubated with prazosin. PD123319 and N(G)-nitro-L-arginine methyl ester [nitric-oxide (NO) synthase inhibitor)] markedly inhibited the relaxant response of Ang II. In contrast, losartan did not produce any significant effect. Consequently, results show that the mechanism underlying the AT(2)-mediated effect is highly dependent on NO generation. Results indicate the presence of a heterogeneous angiotensin receptor population in the rat anococcygeus muscle following a negative cross-talk relationship between the AT(1) and AT(2) subtypes.</abstract><cop>United States</cop><pmid>12235268</pmid><doi>10.1124/jpet.102.036970</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 2002-10, Vol.303 (1), p.333-339
issn 0022-3565
language eng
recordid cdi_proquest_miscellaneous_72093930
source Freely Accessible Journals
subjects Angiotensin II - pharmacology
Animals
Imidazoles - pharmacology
Kinetics
Losartan - pharmacology
Male
Muscle Contraction - drug effects
Muscle, Smooth - drug effects
Muscle, Smooth - physiology
NG-Nitroarginine Methyl Ester - pharmacology
Prazosin - pharmacology
Pyridines - pharmacology
Rats
Rats, Wistar
Receptor Cross-Talk - physiology
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Receptors, Angiotensin - physiology
title Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cross-talk%20between%20AT(1)%20and%20AT(2)%20angiotensin%20receptors%20in%20rat%20anococcygeus%20smooth%20muscle&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=de%20Godoy,%20M%C3%A1rcio%20A%20F&rft.date=2002-10&rft.volume=303&rft.issue=1&rft.spage=333&rft.epage=339&rft.pages=333-339&rft.issn=0022-3565&rft_id=info:doi/10.1124/jpet.102.036970&rft_dat=%3Cproquest_pubme%3E72093930%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p139t-5b499a0e8d5ac672f066d939391c45e376cb7c7bf39397eb3c5b4c295a7802f03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72093930&rft_id=info:pmid/12235268&rfr_iscdi=true